Abstract
Background: In 2018, the National Comprehensive Cancer Network treatment guidelines began recommending the use of neck dissection during surgical management of stage I-II supraglottic laryngeal squamous cell carcinoma (LSCC). Methods: Trends and factors associated with the use of neck dissection during larynx-preserving surgery for patients with cT1-2, N0, M0 supraglottic LSCC in the National Cancer Database (2004–2020) were evaluated using multivariable-adjusted logistic regression. Results: Of the 2080 patients who satisfied study eligibility criteria, 633 (30.4%) underwent neck dissection. Between 2018 and 2020, the rate of neck dissection was 39.0% (114/292). After multivariable adjustment, academic facility type, undergoing biopsy prior to surgery, and more radical surgery were significant predictors of receiving neck dissection. Conclusions: The results of this national analysis suggest that the utilization of guideline-concordant neck dissection for management of stage I-II supraglottic LSCC remains low and highlight the need to promote the practice of neck dissection for this patient population.
Original language | English |
---|---|
Pages (from-to) | 1589-1600 |
Number of pages | 12 |
Journal | Head and Neck |
Volume | 46 |
Issue number | 7 |
DOIs | |
State | Published - Jul 2024 |
Keywords
- elective neck dissection
- guideline-concordant treatment
- laryngeal squamous cell carcinoma
- larynx-preserving surgery
- supraglottic cancer